| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/11/2010 | CA2732283A1 Immunity-inducing agent |
| 02/10/2010 | EP2151497A2 Chimeric U2 snRNA molecules carrying antisense sequences against the splice junctions of the dystrophin gene and their therapeutic applications |
| 02/10/2010 | EP2151454A2 Platelet-derived growth factor D, DNA coding therefor, and uses thereof |
| 02/10/2010 | EP2151451A1 Composition for preventing or treating lung disease |
| 02/10/2010 | EP2151244A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/10/2010 | EP2150618A1 Il-12 immunotherapy for cancer |
| 02/10/2010 | EP2150561A1 Demannosylated recombinant factor vii for the treatment of patients with haemophilia a |
| 02/10/2010 | EP2150558A1 Novel tetrahydrocarbazole derivatives as ligands of g-protein coupled receptors |
| 02/10/2010 | EP2150537A2 High temperature stable peptide formulation |
| 02/10/2010 | EP2150272A1 Means and methods for enhancing weight gain in poultry |
| 02/10/2010 | EP2150270A2 Methods and compositions for the treatment of cancer |
| 02/10/2010 | EP2150269A1 New cyclic peptide compounds |
| 02/10/2010 | EP2150268A1 Compositions for prevention of adhesions and other barrier applications |
| 02/10/2010 | EP2150267A1 Pharmaceutical and/or cosmetic composition containing a cytochrome c-activating active ingredient |
| 02/10/2010 | EP2150266A1 Pharmaceutical and/or cosmetic composition containing an active ingredient which is antioxidant and which activates cell energy |
| 02/10/2010 | EP2150265A1 Inhibitors of acetyl-coa carboxylase for treatment of neuronal hypometabolism |
| 02/10/2010 | EP2150264A1 Stabilization of liquid solutions of recombinant protein for frozen storage |
| 02/10/2010 | EP2150243A2 Compositions and methods for enhancing active agent absorption |
| 02/10/2010 | EP1697498B1 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis |
| 02/10/2010 | EP1539226B1 Methods and compositions for improving growth of meat-type poultry |
| 02/10/2010 | EP1537204B1 Granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells |
| 02/10/2010 | EP1404659B1 4-aryl quinols and analogs thereof as therapeutic agents |
| 02/10/2010 | CN101646451A An insulinotropic complex using an immunoglobulin fragment |
| 02/10/2010 | CN101646450A Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors |
| 02/10/2010 | CN101646449A Compositions and methods for treating and diagnosing cancers |
| 02/10/2010 | CN101646448A Growth hormone secretion stimulator |
| 02/10/2010 | CN101646447A Mycobacterium tuberculosis persistance genes |
| 02/10/2010 | CN101646446A Rankl产生抑制剂 Rankl production inhibitor |
| 02/10/2010 | CN101643789A RNA interference mediating small RNA molecules |
| 02/10/2010 | CN101643732A A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 02/10/2010 | CN101643512A Novel immunoadhesin for the prevention of rhinovirus infection |
| 02/10/2010 | CN101642565A Method for preparing oxygen carrier freeze-dried preparation of haemoglobin |
| 02/10/2010 | CN101642564A Method for preparing alpha interferon vagina effervescent tablets |
| 02/10/2010 | CN101642563A Pilatory containing Wnt protein |
| 02/10/2010 | CN101642562A Preparation method of pharmaceutical preparation and injection of exenatide acetate |
| 02/10/2010 | CN101642561A New application of exenatide acetate and medicine aiming at new application |
| 02/10/2010 | CN101642560A Antitumor pharmaceutical composition |
| 02/10/2010 | CN101642559A Pharmaceutical composition containing micronized human vascular endostatin |
| 02/10/2010 | CN100588660C Antigenic determinant of SARS coronavirus nucleocapsid protein and application thereof |
| 02/10/2010 | CN100588422C Oral insulin composition and methods of making and using thereof |
| 02/09/2010 | US7659405 Protease inhibitor; viricides; purity; crystal structure; mixing tank |
| 02/09/2010 | US7659391 Method for the in vitro synthesis of short double stranded RNAs |
| 02/09/2010 | US7659390 For modulating the expression of genes associated with respiratory and pulmonary disease, such as cholinergic muscarinic receptor genes; nucleic acids with a pyrimidine modification |
| 02/09/2010 | US7659389 RNA interference mediated inhibition of MYC and/or MYB gene expression using short interfering nucleic acid (siNA) |
| 02/09/2010 | US7659385 Polynucleotides encoding molecules designated LDCAM |
| 02/09/2010 | US7659377 Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer |
| 02/09/2010 | US7659375 Interleukin specific immunoglobulin for prevention and treatment of vision, autoimmune, inflammatory and diabetic disorders |
| 02/09/2010 | US7659373 Producing such EPO products characterized by a high proportion of N-acetyl-lactosamine units or/and tetraantennary branches in the carbohydrate structure |
| 02/09/2010 | US7659372 Menstrual fluid simulant containing blood product, gelatin, polyacrylamide and buffer |
| 02/09/2010 | US7659370 Nervous system protein for use in treatment and prevention of nervous system and seizure disorders |
| 02/09/2010 | US7659368 ErbB2 and ErbB3 chimeric heteromultimer adhesins |
| 02/09/2010 | US7659367 Contains insulin-like growth factor-I, insulin-like growth factor binding protein 3 and integrin-binding domain of vitronectin ; wound healing; surgical implant, prosthesis, scaffold, wound or burn dressing |
| 02/09/2010 | US7659364 Decyclization of an oxazolidinone compound; N-methylmethionine chemical intermediates |
| 02/09/2010 | US7659363 Process for the preparation of insulin or an insulin derivative in the presence of oxygen |
| 02/09/2010 | US7659362 Metal-binding motif compositions and methods |
| 02/09/2010 | US7659311 Delivery of agents such as heparin and calcitonin; greater efficacy; disodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid |
| 02/09/2010 | US7659255 Methods of inhibiting glutamate receptors by administering the tripeptide KDI |
| 02/09/2010 | US7659254 Abuse-resistant amphetamine prodrugs |
| 02/09/2010 | US7659253 Abuse-resistant amphetamine prodrugs |
| 02/09/2010 | US7659252 Transdermal delivery peptides and method of use thereof |
| 02/09/2010 | US7659251 Ligand for G-protein coupled receptor FPRL2 |
| 02/09/2010 | US7659250 BMP-7 variant compositions, methods and uses |
| 02/09/2010 | US7659249 Membrane-permeable NFAT inhibitory peptide |
| 02/09/2010 | US7659248 a solubilizing agent, an antioxidant, and a buffer; improved storage stability and oxidation resistance |
| 02/09/2010 | US7659246 Use of cyclic peptide of given structure which is a C5a G protein-coupled receptor inhibitor |
| 02/09/2010 | US7659245 flavivirus antivirals based on1,6-diazacyclotetradecane with fused pyrrolidine or cyclopentane ring at positions 3,4 and methylene bridge at positions 7,8; macrocyclic ring substituted with quinazolin-4-yloxy substituent on the fused pyrrolidine or cyclopentane ring |
| 02/09/2010 | US7659244 Rapamycin peptides conjugates: synthesis and uses thereof |
| 02/09/2010 | US7659243 Treatment of ALS and variants thereof consisting of primary lateral sclerosis (PLS) or spinal muscular atrophy (SMA) |
| 02/09/2010 | US7659242 Composition comprising protein material and compounds comprising non-oxidizable fatty acid entities |
| 02/09/2010 | US7659241 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 02/09/2010 | US7659119 Method and compositions for obtaining mature dendritic cells |
| 02/09/2010 | US7659115 Nucleic acid encoding human transductin-1 polypeptide |
| 02/09/2010 | US7659093 DAP12 nucleic acids |
| 02/09/2010 | US7659091 Diagnostic marker |
| 02/09/2010 | US7659081 Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith |
| 02/09/2010 | US7659071 Using cell-mediated immune response to e6 and e7 peptides as diagnostic/prognostic indication of recurrence and/or development of cervical intraepithelial neoplasia (CIN) |
| 02/09/2010 | US7658939 Inert core, first layer comprising naltrexone, nalmefene or salts; and second hydrophobic layer; pain treatment |
| 02/09/2010 | US7658935 Methods and compositions for stimulating the immune system |
| 02/09/2010 | US7658923 Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26 |
| 02/09/2010 | US7658920 Method of inhibiting the activity of growth factor homolog ZVEGF3 |
| 02/09/2010 | US7658918 Stable digestive enzyme compositions |
| 02/09/2010 | US7658917 A beta aggregation core domain and a modifying group coupled thereto such that the compound alters the aggregation or inhibits the neurotoxicity of natural beta amyloid peptides when contacted with the peptides. |
| 02/09/2010 | US7658916 Methods of enhancing lysosomal storage disease therapy by modulation of cell surface receptor density |
| 02/09/2010 | CA2485977C Short chain polymer for enhancing the bioadhesiveness of polymers on mucosal membrane |
| 02/09/2010 | CA2431079C Method and composition for the treatment of diabetic neuropathy |
| 02/09/2010 | CA2404945C Taci as an anti-tumor agent |
| 02/09/2010 | CA2378431C Peptides that lower blood glucose levels |
| 02/09/2010 | CA2349875C Dna encoding a growth factor specific for epithelial cells |
| 02/09/2010 | CA2334222C Insulin supplemented infant formula |
| 02/09/2010 | CA2330925C Pharmaceutical formulations for igf/igfbp |
| 02/09/2010 | CA2293806C Alpha 1-antitrypsin preparation as well as a method for producing the same |
| 02/09/2010 | CA2287469C Interactive system for presenting and eliminating substances |
| 02/09/2010 | CA2286614C Plant extracts for the treatment of increased bone resorption |
| 02/09/2010 | CA2256532C Immunodominant 120 kda surface-exposed adhesion protein genes of ehrlichia chaffeensis |
| 02/09/2010 | CA2235810C Senescent cell-derived inhibitors of dna synthesis |
| 02/09/2010 | CA2205910C Plasmids suitable for il-2 expression |
| 02/09/2010 | CA2195799C Bacterial production of hydrophobic polypeptides |
| 02/09/2010 | CA2150933C Glaucoma treatment |
| 02/04/2010 | WO2010014948A1 Methods of treatment using wnt inhibitors |
| 02/04/2010 | WO2010014946A2 Halogen-stabilized insulin |